Novel roles of vitamin D in disease: What is new in 2011?

被引:123
作者
Makariou, Stefania [1 ,2 ]
Liberopoulos, Evangelos N. [2 ]
Elisaf, Moses [2 ]
Challa, Anna [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Child Hlth, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
Vitamin D; Mortality; Metabolic syndrome; Cardiovascular disease; Immune system; Cancer; 3RD NATIONAL-HEALTH; CARDIOVASCULAR RISK-FACTORS; PARATHYROID-HORMONE LEVELS; CONGESTIVE-HEART-FAILURE; PROSTATE-CANCER RISK; D-RECEPTOR GENE; D SUPPLEMENTATION; METABOLIC SYNDROME; BLOOD-PRESSURE; D DEFICIENCY;
D O I
10.1016/j.ejim.2011.04.012
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Vitamin D is a steroid molecule, mainly produced in the skin that regulates the expression of a large number of genes. Until recently its main known role was to control bone metabolism and calcium and phosphorus homeostasis. During the last 2 decades it has been realized that vitamin D deficiency, which is really common worldwide, could be a new risk factor for many chronic diseases, such as the metabolic syndrome and its components, the whole spectrum of cardiovascular diseases, several auto-immune conditions, and many types of cancer as well as all-cause mortality. Except for the great number of epidemiological studies that support the above presumptions, vitamin D receptors (VDRs) have been identified in many tissues and cells. The effect of vitamin D supplementation remains controversial and the need for more persuasive study outcomes is intense. (C) 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 127 条
[1]
Serum 25(OH)-Vitamin D concentration and risk of esophageal squamous dysplasia [J].
Abnet, Christian C. ;
Chen, Wen ;
Dawsey, Sanford M. ;
Wei, Wen-Qiang ;
Roth, Mark J. ;
Liu, Bing ;
Lu, Ning ;
Taylor, Philip R. ;
Qiao, You-Lin .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (09) :1889-1893
[2]
The role of vitamin D in left ventricular hypertrophy and cardiac function [J].
Achinger, SG ;
Ayus, JC .
KIDNEY INTERNATIONAL, 2005, 67 :S37-S42
[3]
Antiproteinuric effect of oral paricalcitol in chronic kidney disease [J].
Agarwal, R ;
Acharya, M ;
Tian, J ;
Hippensteel, RL ;
Melnick, JZ ;
Qiu, P ;
Williams, L ;
Batlle, D .
KIDNEY INTERNATIONAL, 2005, 68 (06) :2823-2828
[4]
Serum vitamin D concentration and prostate cancer risk: A nested case-control study [J].
Ahn, Jiyoung ;
Peters, Ulrike ;
Albanes, Demetrius ;
Purdue, Mark P. ;
Abnet, Christian C. ;
Chatterjee, Nilanjan ;
Horst, Ronald L. ;
Hollis, Bruce W. ;
Huang, Wen-Yi ;
Shikany, James M. ;
Hayes, Richard B. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (11) :796-804
[5]
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease - A randomized double-blind pilot trial [J].
Alborzi, Pooneh ;
Patel, Nina A. ;
Peterson, Carla ;
Bills, Jennifer E. ;
Bekele, Dagim M. ;
Bunaye, Zerihun ;
Light, Robert P. ;
Agarwal, Rajiv .
HYPERTENSION, 2008, 52 (02) :249-255
[6]
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? [J].
Amital, H. ;
Szekanecz, Z. ;
Szucs, G. ;
Danko, K. ;
Nagy, E. ;
Csepany, T. ;
Kiss, E. ;
Rovensky, J. ;
Tuchynova, A. ;
Kozakova, D. ;
Doria, A. ;
Corocher, N. ;
Agmon-Levin, N. ;
Barak, V. ;
Orbach, H. ;
Zandman-Goddard, G. ;
Shoenfeld, Y. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) :1155-1157
[7]
Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
[8]
[Anonymous], AM J EPIDEMIOLOGY
[9]
[Anonymous], 2008, IARC WORK GROUP VIT
[10]
Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials [J].
Autier, Philippe ;
Gandini, Sara .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1730-1737